Category
Oral Antidiabetic
Form
Tablets
Strength
80mg
CAS
21187-98-4
Gliclazide Tablets – Effective Blood Glucose Control Therapy
Second-generation sulfonylurea antidiabetic. Stimulates insulin secretion from pancreatic beta cells. 80mg oral tablet formulation. Supports stable glycemic control. Manufactured under global pharmaceutical standards.
Gliclazide Tablets are widely used oral antidiabetic medications belonging to the sulfonylurea class. Identified by CAS Number 21187-98-4, it ensures pharmaceutical-grade quality. It works by stimulating pancreatic beta cells to release insulin. Provides effective glycemic control in patients with Type 2 diabetes. Manufactured under strict international pharmaceutical standards.
Request QuoteOverview
- Oral hypoglycemic agent.
- Enhances insulin secretion.
- Reduces blood glucose levels.
- Used in Type 2 diabetes management.
- Reliable oral antidiabetic therapy.
Introduction
- Gliclazide Tablets are widely used oral antidiabetic medications belonging to the sulfonylurea class.
- Identified by CAS Number 21187-98-4, it ensures pharmaceutical-grade quality.
- It works by stimulating pancreatic beta cells to release insulin.
- Provides effective glycemic control in patients with Type 2 diabetes.
- Manufactured under strict international pharmaceutical standards.
Important Information
- Belongs to sulfonylurea class.
- CAS 21187-98-4 ensures traceability.
- Available in 80mg strength.
- Oral tablet formulation.
- Requires medical supervision.
Dosage
General
- Initial dose: 40–80mg daily
- Maintenance dose: 80–320mg/day
- Dose adjusted based on patient response
Administration
- Take with meals
- Swallow with water
- Maintain consistent dosing schedule
- Do not skip meals
Important
- Use under medical supervision
- Monitor blood glucose regularly
- Avoid overdose
Storage
- Store below 25°C
- Protect from moisture and heat
- Keep in original packaging
- Keep out of reach of children
Shelf Life
- Typical shelf life: 24–36 months
- Use before expiry date
- Proper storage ensures stability
Manufacturing
- Manufactured in WHO-GMP certified facilities
- High-purity API (CAS 21187-98-4)
- Advanced tablet formulation technology
- Uniform drug distribution
- Multi-stage quality testing
- Global regulatory compliance
Precautions
- Risk of hypoglycemia if meals are skipped
- Use cautiously in elderly patients
- Monitor kidney and liver function
- Avoid alcohol consumption
- Not suitable for Type 1 diabetes
Side Effects
- Hypoglycemia
- Headache
- Dizziness
- Nausea
- Weight gain
- Skin reactions (rare)
- Liver enzyme changes (rare)
Expert View
- Reliable antidiabetic therapy.
- Effective for long-term glycemic control.
- Widely used globally.
- Requires careful monitoring.
- Strong clinical performance.
Indications
- Type 2 diabetes mellitus
- Patients uncontrolled by diet and exercise
- Combination therapy with other antidiabetics
- Long-term glycemic control
Maintenance
- Long-term therapy under supervision
- Regular blood glucose monitoring
- Dose adjustment as needed
- Lifestyle management required
- Follow medical advice strictly
Why Choose
- Proven sulfonylurea therapy
- Effective glycemic control
- WHO-GMP certified manufacturing
- Reliable global supply
- Consistent product quality
Frequently Asked Questions
Common product and supply questions.
What are gliclazide tablets used for?+-
Gliclazide tablets are used to treat Type 2 diabetes by lowering blood sugar levels and improving insulin secretion.
What is the last stage of diabetes?+-
Advanced diabetes can lead to complications such as kidney failure, nerve damage, and cardiovascular disease.
Is gliclazide the same as metformin?+-
No, gliclazide increases insulin secretion, while metformin reduces glucose production.
How long can you stay on gliclazide?+-
It can be used long-term under medical supervision with regular monitoring.
Is gliclazide safe for kidneys?+-
It may be used in mild kidney disease with proper monitoring and dose adjustment.